Pre-vaccine rotavirus surveillance in Buenos Aires, Argentina: Characterization of an emergent G1P[8] strain associated to fatal cases in 2014 by Mandile, Marcelo Gastón et al.
Journal Pre-proof
Pre-vaccine rotavirus surveillance in Buenos Aires, Argentina.
Characterization of an emergent G1P[8] strain associated to fatal
cases in 2014
Marcelo G. Mandile, Marcelo H. Argüelles, Carlos F. Temprana,
Estefanía S. Peri Ibáñez, Dalila Silvestre, Alejandra Musto,





To appear in: Infection, Genetics and Evolution
Received date: 25 November 2019
Revised date: 8 January 2020
Accepted date: 9 January 2020
Please cite this article as: M.G. Mandile, M.H. Argüelles, C.F. Temprana, et al., Pre-
vaccine rotavirus surveillance in Buenos Aires, Argentina. Characterization of an
emergent G1P[8] strain associated to fatal cases in 2014, Infection, Genetics and
Evolution(2019), https://doi.org/10.1016/j.meegid.2020.104192
This is a PDF file of an article that has undergone enhancements after acceptance, such
as the addition of a cover page and metadata, and formatting for readability, but it is
not yet the definitive version of record. This version will undergo additional copyediting,
typesetting and review before it is published in its final form, but we are providing this
version to give early visibility of the article. Please note that, during the production
process, errors may be discovered which could affect the content, and all legal disclaimers
that apply to the journal pertain.





Pre-vaccine rotavirus surveillance in Buenos Aires, Argentina. Characterization of 
an emergent G1P[8] strain associated to fatal cases in 2014. 
 
Authors 
Marcelo G. Mandile a, b, * (mgmandile@gmail.com) 
Marcelo H. Argüelles a (marcelo.h.arguelles@gmail.com) 
Carlos F. Temprana a, b (ctemprana@unq.edu.ar) 
Estefanía S. Peri Ibáñez a, b (peri.estefania@gmail.com) 
Dalila Silvestre a, b (silvestre.dalila@gmail.com) 
Alejandra Musto c (musto.alejandra@gmail.com) 
Alberto Rodríguez Pérez d (arodperez@gmail.com) 
Alicia Mistchenko e (virologiahnrg@gmail.com) 
Graciela Glikmann a (gglikman@unq.edu.ar) 
Alejandro A. Castello a, f (castelloaa@gmail.com) 
 
Institutional affiliations 
a Laboratorio de Inmunología y Virología, Universidad Nacional de Quilmes, Roque 
Sáenz Peña 352, Bernal (1876), Buenos Aires, Argentina 
b Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy 
Cruz 2290 (1425), Ciudad Autónoma de Buenos Aires, Argentina 
c Hospital Interzonal de Agudos Evita Pueblo, Rio de Janeiro 1910, Lanús Oeste 
(1824), Buenos Aires, Argentina  













(1803), Buenos Aires, Argentina  
e Laboratorio de Virología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, 
Buenos Aires (1425), Argentina 
f Instituto de Ciencias de la Salud, Universidad Nacional Arturo Jauretche, Félix 
Lope de Vega 2099, Florencio Varela (1888), Buenos Aires, Argentina 
 
* Corresponding author: 
Postal Address: Laboratorio de Inmunología y Virología, Universidad Nacional de 
Quilmes, Roque Sáenz Peña 352, Bernal (1876), Buenos Aires, Argentina. 
Email Address: mgmandile@gmail.com (M. Mandile). 
Tel: +54 11 43657100 ext. 5634. Fax: +54 11 43657101 
 
Abstract word count: 288 words 















Rotavirus; Reemergence; Vaccines; Phylogeny; Argentina. 
 
1. Introduction 
Group A rotaviruses (RVA) are the most important etiological agents of severe 
gastroenteritis in infants and young children worldwide [WHO, 2013; Estes, 2007]. Two 
RVA vaccines were licensed since 2006, Rotarix (monovalent, RV1), and RotaTeq 
(pentavalent, RV5). Within the first years following vaccine introduction, a substantial 
decline in rotavirus gastroenteritis hospitalizations among children <5 years of age has been 
observed [Parashar et al., 2013]. Nonetheless, RVA infections are responsible for an 
estimated 200,000 deaths each year in children under five years of age, with around 90% of 
these fatalities occurring in poor regions [Parashar et al., 2013, Clark et al., 2017]. 
Following the recommendations of the World Health Organization [WHO, 2013], Argentina 
has introduced rotavirus vaccination by incorporating RV1 in the National Immunization 
Schedule since January 2015. 
Rotaviruses are nonenveloped viruses, and their genome consists of 11 double-
stranded RNA segments. The two outer capsid proteins, VP7 (glycoprotein) and VP4 
(protease-cleaved protein), defines the G and P types, respectively [Estes, 2007] and have 
been extensively used in epidemiological studies for strains characterization. In recent years 
a uniform, sequence-based classification system for the eleven segments was developed, 
and genotypes were defined for each segment using a letter indicating the coding gene 
followed by a number indicating the genotype [Matthijnssens et al., 2008]. The majority of 
all human RVA strains belong to one of two typical genotype constellations: the Wa-like 













N1-T1-E1-H1 associated with G1, 3, 4, 9 or 12, and P[8] combinations; while I2-R2-C2-
M2-A2-N2-T2-E2-H2 with G2 and P[4] combination characterizing DS-1-like strains. 
It is known from studies on strain phylodynamics that new reassortants could spread 
worldwide in a short time [Matthijnssens et al., 2010] owned to the globalization. This fact 
is a major concern that warrants continuing surveillance for RVA morbidity, disease 
severity, and vaccine effectiveness, especially in low-income countries where RVA 
evolution is highly dynamic and vaccine effectiveness has been suboptimal [Burnett et al., 
2016]. In consequence, the molecular epidemiology represents an important tool used 
globally to study the natural pattern in the strains replacement and, especially, to detect the 
early emergence of new variants. Based on this type of studies our group has reported the 
emergence or reemergence of relevant strains on several occasions [Castello et al., 2006; 
Castello et al., 2009; Esteban et al., 2010; Mandile et al., 2014]. Therefore, the purpose of 
this study was to analyze the molecular epidemiology of RVA in Buenos Aires from 2012 
through 2014 to obtain a global view of RVA strains affecting Argentina before the 
beginning of massive RV1 vaccination. Furthermore, we decided to emphasize the 
phylogenetic, epidemiologic, and clinical characterization of a particular G1P[8] strain 
since it was associated with severe cases of RVA associated gastroenteritis and five 
fatalities in 2014. 
 
2. Materials and methods 
2.1. Sample Collection 
The samples were obtained from the Children´s Hospital “Dr. Ricardo Gutierrez” 
(HNRG), one of the biggest hospitals in Buenos Aires city (CABA), assisting patients from 













The population of this area is estimated at 13 million people, making it the first urban area 
of Argentina and the second in South America 
[https://www.buenosaires.gob.ar/laciudad/ciudad]. A total of 1394 fecal specimens were 
studied in the mentioned Hospital between January 2012 and December 2014. From these, 
296 samples testing positive for RVA were submitted to our laboratory at the Universidad 
Nacional de Quilmes (UNQ) for further molecular characterization. For an additional study 
of the strains causing severe cases of gastroenteritis in 2014, two extra sets of samples were 
obtained from children with acute diarrhea admitted at the Hospital “Dr. Alberto 
Eurnekian” (HAE) in Ezeiza (30 samples) and the Hospital “Evita” (HE) in Lanús (six 
samples), located at 30 and 10 kilometers out of CABA respectively. These samples were 
analyzed at the UNQ for the presence of RVA with an in-house ELISA described elsewhere 
[Argüelles et al., 2000], resulting in a total of 27 RVA positive samples (21 from HAE and 
six from HE). 
2.2. Epidemiological information 
From the HNRG Virology Laboratory records, information about the incidence of 
hospitalized diarrhea cases discriminating between positive and negative samples for RVA, 
ages, location, and dates was compiled from 2008 through 2014.  
2.3. RNA Extraction and genotyping by RT–PCR 
Viral RNA was extracted from rotavirus-positive stool specimens by the silica 
powder method [Boom et al., 1990]. Extracted RNA was denatured at 97°C for 5 min, and 
the first amplification of VP7, VP4, VP6, or NSP4 segments was performed by RT-PCR 
with the One-Step RT-PCR kit (QIAGEN GmbH, Germany) with gene-specific consensus 
primers. For G typing, consensus primers VP7F and VP7R [Iturriza-Gómara et al., 2001] 













specific forward primers in the second round PCR [Banerjee et al., 2007; Gouvea et al., 
1990, Iturriza-Gómara et al., 2004]. For P typing, consensus primers VP4F and VP4R 
[Simmonds et al., 2008] were used in the first round RT-PCR and the VP4F primer with a 
set of P type-specific primers in the second round PCR [Gentsch et al., 1992; Iturriza-
Gómara et al., 2000]. Cycle conditions and visualization of PCR products were conducted 
as reported previously [Esteban et al., 2010]. 
2.4. Nucleotide Sequence Analysis 
Sequence analysis of the genes from G1P[8] strains associated with severe cases in 
the cold season of 2014 was performed using the RT-PCR amplification products. Briefly, 
PCR products were gel-purified with the QIAquick gel extraction kit (QIAGEN GmbH, 
Hilden, Germany) and sequenced with the automated sequencer ABI3730XL under BigDye 
terminator cycling conditions (Macrogen Inc., Korea). The nucleotide sequences presented 
in this article were submitted to the databases at the National Center for Biotechnical 
Information (NCBI) at the National Library of Medicine and recorded under the GenBank 
accession numbers: KU145625-KU145654. 
2.5. Phylogenetic Analysis 
Phylogenetic trees were reconstructed using the neighbor-joining method, and the 
evolutionary distances between nucleotide sequences were estimated by the Kimura-2 
parameter method. The bootstrap probability was calculated for each internal branch of the 
phylogenetic trees with 1,000 times of resampling. These analyses were conducted using 
the software MEGA [Tamura et al., 2011]. 
3. Results 













In the present study, we report for the first time the G and P genotypes for the period 
2012-2014. As it can be seen in Table 1,  in 2012, approximately even amounts of three G 
genotypes were seen: 38.2% of G3, 29.4% of G12 and 26.5% of G2; with rates of P[8] and 
P[4] of 56% and 32%,  respectively, as expected for regions with co-circulation of typical 
G-P combinations of Wa and DS-1 like strains. In 2013, the G12 genotype became sharply 
dominant (60.9%); meanwhile, G3 and G2 were detected in 21.7% and 8.7% of the 
samples, respectively. In the following year, 2014, and after nine years of virtual absence 
[Esteban et al., 2010; Mandile et al., 2014], the G1 genotype reemerged, representing the 
68.8% of the total G-typed strains. Interestingly, these G1P[8] strains were associated with 
particularly severe cases causing five fatalities and thus were further characterized in this 
study. 
Along with this study, 19 years of continuous RVA genotype surveillance in 
Argentina [Argüelles et al. 2000; Castello et al., 2006; Castello et al., 2009; Esteban et al., 
2010; Mandile et al., 2014] was covered. Thus, in order to contextualize the results 
obtained for the analyzed 2012-2014 period, the genotypes fluctuations form 1996 to 2014 
are depicted in Figure 1. 
For the period 2012-2014, 21.2% of the 1394 fecal samples studied for RVA in the 
HNRG were positive (RVA+). The RVA positivity rates for each year were 20.0% (86 
RVA+ from 429 analyzed samples), 18.2% (67 RVA+ from 367 analyzed samples) and 
23.9% (143 RVA+ from 598 analyzed samples) in the years 2012, 2013 and 2014, 
respectively. Notably, the subgroup of RVA positive hospitalized patients was significantly 
younger than the group testing negative (p< 0.0001, t Student test) with a mean of 15.4 
months (median: 8.6, SD: 23.2, rank: 0.3-156) and a mean of 28.0 months (median: 12.6, 













Since data from HNRG was available for every year between 2008 and 2014, we 
decided to explore the particularities of this last year when G1P[8] strains reemerged. 
Significant differences in the number of hospitalized patients and their ages could be 
appreciated between the mean values of the 2008-2013 period and the year 2014. During 
the cold season of this year (May-August), a total of 130 patients were hospitalized in 
HNRG due to RVA associated diarrhea, a number significantly higher (p<0.0001, z test) 
than the mean for the period 2008-2013 (61.8, SD 28.3) as can be graphically appreciated 
in the figure 2. Additionally, the mean age of patients suffering RVA associated 
gastroenteritis during 2014 was 12.4 months (median: 9.4, SD: 9.8) which was significantly 
higher (p< 0.01, t Student test) than the mean of 9.9 months (median: 8.0 months, SD: 7.9 
months) for the period 2008-2013.  
3.2. VP7 phylogeny from the G1P[8] strains 
A phylogenetic study of the VP7 gene, including most of the available sequences of 
Argentine and regional strains and also representative global G1 isolates, is depicted in 
figure 3. As can be appreciated, different lineages and sublineages related to several global 
or regional G1 strains have circulated in our country during the last thirty years. In the 
present work, six samples from the year 2014, and one from 2013 were successfully 
sequenced.  Sequences analysis showed that all belong to the lineage II, a lineage that has 
never been reported previously in Argentina. These sequences clustered together and were 
closely related (99% nucleotide identity) to a group of Thai, Vietnamese, and Russian 
strains circulating between 2012 and 2014. This group of sequences is a little more 
distantly related to European and South African strains from 2009 and 2011, and to the 
subgroup of DS-1 like G1P[8] strains circulating in Asia, Africa, and Brazil during 2012 













Furthermore, from the deduced aminoacidic sequences of VP7 protein (data not shown), we 
have detected a remarkable change in the 2013-2014 strains when compared to those 
previously characterized. The amino acid N or S in the position 147 is replaced by a D, 
exchanging a polar non-charged amino acid by a charged one within the antigenic region B. 
Interestingly, this change is only present in the Argentine strains from 2013 and 2014 and 
those circulating in Vietnam, Russia and Thailand during 2012 and 2013. Although this 
finding does not allow us to ensure the association of the mutation with the severity of the 
cases, it prompts us to continue with these studies to understand whether or not this 
association exists. 
3.3. VP4 phylogeny from the G1P[8] strains 
In the present work, 15 VP4 genes were partially sequenced from samples 
characterized as P[8] genotype, seven in combination with G1 (four from 2014 and three 
from 2008), and eight in combination with G12 or G4. As can be observed in figure 4, all 
these Argentine sequences belong to the lineage III, but clustering in five markedly 
different groups. In particular, sequences associated with the G1 genotype are included in 
three of those clusters. The phylogram shows that the sequences from 2008 are 
heterogeneous, appearing in two groups; meanwhile, the sequences circulating during 2014 
are much more homogeneous grouping in a single cluster. Consistent with the findings 
showed above based on the VP7 gene, the sequences of the VP4 gene from the G1P[8] 
strains circulating in 2014 are related to Asian strains circulating from 2012 through 2014, 
but not related to G1P[8] DS-1-like strains. 
3.4. NSP4 phylogeny from the G1P[8] strains 
The NSP4 gene from seven G1P[8] strains was sequenced, five from the year 2014, 













cluster in two different groups in accordance with the year of isolation (figure 5). This 
phylogenetic study further confirms the results described earlier about the close relationship 
of the Argentine strains from 2014 with the strains circulating in Vietnam in 2012 and 2013. 
Meanwhile, the NSP4 genes of the Argentine G1P[8] strains from 2008 have close 
relationships with strains circulating in Europe and America between 2001 and 2008. 
3.5. VP6 phylogeny from the G1P[8] strains 
The VP6 gene from six G1P[8] strains was sequenced, four were from the year 
2014, and two from 2008. These sequences belong to the I1 genotype, lineage 1, but they 
cluster in two different groups in accordance with the year of isolation (figure 6). This 




In the present work, we analyzed the circulation of RVA genotypes in the period 
2012-2014 in GBA, completing a panoramic view of the pre-vaccine era along 19 years by 
revisiting our previous reports [Argüelles et al., 2000; Castello et al., 2006; Esteban et al., 
2010; Mandile et al., 2014]. During the last year of this surveillance, we detected an 
emerging rotavirus G1P[8] strain causing severe cases of gastroenteritis and five fatalities. 
Thus, we explore further this emerging strain by sequencing of four genes and examining 
some of their epidemiological characteristics.  
In the analyzed period 2012-2014, we found that 21.2% of the fecal samples tested 
in the HNRG resulted positive for RVA, with the mean age of the patients of 15.4 months. 
Interestingly, significantly more cases of RVA associated gastroenteritis were hospitalized 













through August) of 2014 when compared with the previous six cold seasons (2008-2013). 
These facts could be attributed to an epidemic outbreak of RVA dominated by a more 
virulent strain or, most probably, considering the older ages of the patients, due to a strain 
that has not been circulating in our population for a long time. Deficient immunity toward a 
less prevalent genotype could be a factor involved in this high incidence, as was previously 
argued for G2 genotype in gastroenteritis outbreaks among school-aged children and adults 
[Griffin et al., 2002, Mikami et al., 2004]. A closer analysis of the patients’ age distribution 
for the 2014 cold season shows that a large number of RVA cases were in the range of 16-
24 months of age. At this lifetime, the probability of previous first contact with RVA is 
high, suggesting low heterotypic protection from previous infection/s. From an 
epidemiological point of view, the low detection rate of the G1 genotype between 2005 and 
2013 in our area may be a factor determining this incomplete or inefficient immunity 
against the emerging G1P[8] strains among the general population. 
The particular epidemiologic characteristics of the year 2014, including the death of 
five children associated with RVA infection, prompt us to investigate further the dominant 
G1P[8] strain. The high genetic homogeneity found for the VP7 gene and the fact that, to 
the best of our knowledge, they belong to a lineage that has not been previously detected in 
Argentina, suggests a recent introduction. Strikingly, the only G1 strain that could be 
sequenced in 2013 presents a highly related VP7sequence, a fact that would indicate the 
possibility that the strains causing the epidemic outbreak would have been circulating since 
2013 at a low level. However, this cannot be asserted based on a single gene, but, 
unfortunately, we were unable to amplify additional genes from this sample from 2013. 
 The phylogenetic study of the VP7 gene of the five G1P[8] isolates from 2014, and 













group of Thai, Vietnamese, and Russian human strains and a group of Vietnamese porcine 
strains circulating since 2012 [Chieochansin et al., 2016; Phan et al., 2016]. This 
relationship is supported by the sequence study of the other three genes, VP4, VP6, and 
NSP4. At the same time, the absence of reported Brazilian strains, or of some other 
neighboring country, in the same group indicates a new continental introduction through 
Argentina, most probably from Asian countries, from where a previous similar introduction 
was described for G12P[9] strains that circulated in Buenos Aires between the years 1999 
and 2003 [Castello et al., 2006; Castello et al., 2009]. In line with this idea, the 
phylogenetic study also indicated that these Argentine G1P[8] strains were not related to 
the DS-1-like G1P[8] strains that emerged in 2012-2013 in Asia [Nakagomi et al., 2017] 
and were circulating in Brazil during 2013 [Luchs et al., 2019]. 
With this study, we completed 19 years of continuous surveillance of RVA strains in 
the Greater Buenos Aires before the RV1 vaccine was massively implemented in January 
2015. So, this work gives us a whole panorama of the pre-vaccine era of the RVA molecular 
epidemiology in the most populated region of Argentina. In this sense, this information 
represents an important starting point to study and evaluate the impact of the vaccine 
introduction on the RVA epidemiology/ecology in Argentina. In particular, analyze the 
vaccine performance, and to detect emerging strains escaping the vaccine.  
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Figure 1. Prevalence of G and P genotypes in the greater Buenos Aires. 
A. Prevalence of G genotypes in the greater Buenos Aires between 1996 and 2014. 
B. Prevalence of P genotypes in the greater Buenos Aires between 1996 and 2014. 
Percentages were calculated on the basis of the total number of genotypes detected. 
Figure 2. Number of cases of RVA infections from 2008 to 2014. 
Number of patients below five years old hospitalized with RVA associated diarrhea 
on a monthly basis between 2008 and 2014 in the Children´s Hospital Ricardo Gutierrez, 
CABA, Argentina. 
Figure 3. Phylogenetic analysis of the VP7 gene from G1 strains. 
Nucleotide sequences were obtained from the GenBank database or produced for 
this work. The lineages are indicated on the right and the bootstrap values are shown at the 
branch nodes (values <65% are not shown). The Argentine strains analyzed in this study are 
shown in boldface. Strains are named according to the nomenclature proposed by the 
Rotavirus Classification Working Group. 
Figure 4. Phylogenetic analysis of the VP4 gene from G1 strains. 
Nucleotide sequences were obtained from the GenBank database or produced for 
this work. The lineages are indicated on the right and the bootstrap values are shown at the 
branch nodes (values <65% are not shown). The Argentine strains analyzed in this study are 
shown in boldface. Strains are named according to the nomenclature proposed by the 
Rotavirus Classification Working Group. 
Figure 5. Phylogenetic analysis of the NSP4 gene from G1 strains. 
Nucleotide sequences were obtained from the GenBank database or produced for 













branch nodes (values <65% are not shown). The Argentine strains analyzed in this study are 
shown in boldface. Strains are named according to the nomenclature proposed by the 
Rotavirus Classification Working Group. 
Figure 6. Phylogenetic analysis of the VP6 gene from G1 strains. 
Nucleotide sequences were obtained from the GenBank database or produced for 
this work. The lineages are indicated on the right and the bootstrap values are shown at the 
branch nodes (values <65% are not shown). The Argentine strains analyzed in this study are 
shown in boldface. Strains are named according to the nomenclature proposed by the 
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Table 1. Distribution and frequency of G and P genotypes of group A rotavirus from 2012 through 2014 detected in Buenos 
Aires 
Genotype 
2012 2013 2014  
Total no. 
% Over the 








%   
G1 0 0.0 1 4.3 22 68.8   23 25.8 
G2 9 26.5 2 8.7 3 9.4   14 15.7 
G3 13 38.2 5 21.7 0 0.0   18 20.2 
G4 1 2.9 0 0.0 0 0.0   1 1.1 
G10 1 2.9 0 0.0 0 0.0   1 1.1 
G12 10 29.4 14 60.9 6 18.8   30 33.7 
GNT 0 0.0 1 4.3 1 3.1   2 2.2 
Total 34 100.0 23 100.0 32 100.0   89 100.0 
P[4] 8 31.0 2 9.1 3 10.0   13 16.9 
P[8] 14 56.0 18 81.8 25 83.3   57 74.0 
PNT 3 12.0 2 9.1 2 6.7   7 9.1 
Total 25 100.0 22 100.0 30 100.0   77 100.0 
PNT, P not typeable. 















• RVA genotype fluctuation along 19 years in the pre-vaccine era was reviewed 
• Increased incidence of severe RVA associated diarrhoeas during 2014 in Buenos 
Aires 
• The reemergence of G1P[8] strains detected in 2014 was associated with severe 
cases 
• 2014 RVA associated gastroenteritis patients were older than those from last 
years 
• Phylogenetic analyses suggest an extra continental introduction of G1 strains 
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